Category: M&A

Akoya Biosciences Contemplates Buyout Amid Merger Talks

Akoya Biosciences is currently evaluating an unsolicited buyout offer, introducing an unexpected variable into its ongoing merger proceedings with Quanterix. The original acquisition proposal outlined a structure in which Quanterix shareholders would assume a 70% ownership stake, leaving Akoya shareholders with the remaining 30%. Under this framework, Akoya would continue to exist as a wholly […]